Pseudocholinesterase in early infancy.
作者信息
LEHMANN H, COOK J, RYAN E
出版信息
Proc R Soc Med. 1957 Mar;50(3):147-50. doi: 10.1177/003591575705000304.
Abstract
摘要
相似文献
1
Pseudocholinesterase in early infancy.婴儿早期的假性胆碱酯酶。
Proc R Soc Med. 1957 Mar;50(3):147-50. doi: 10.1177/003591575705000304.
2
[Cholinesterase activity and protein concentration in the serum of premature and newborn infants].[早产儿和新生儿血清中的胆碱酯酶活性及蛋白质浓度]
Klin Padiatr. 1987 Mar-Apr;199(2):98-102. doi: 10.1055/s-2008-1026771.
3
[Determination of serum pseudocholinesterase, LDH-1-isoenzyme "alpha-hydroxybutyrate dehydrogenase" and isocitrate dehydrogenase in the premature infant].
Minerva Pediatr. 1971 Mar 17;23(11):467-8.
4
[Thromboelastographic findings in infancy. III. Thromboelastogram of the newborn at term and the premature].
Minerva Pediatr. 1956 Aug 11;8(31-32):981-7.
5
[The determination of glutamic oxalacetic and glutamic pyruvic transminases in the normal and premature newborn infant].
Atti Accad Fisiocrit Siena Med Fis. 1959;6:236-45.
6
[Immune-electrophoretic findings in newborn & premature infants].
Monatsschr Kinderheilkd (1902). 1959 Mar;107(3):108-10.
7
Fibrinogen determinations on premature and normal term infants during the first day of life; relationships to maternal and cord blood at delivery.
Bull Tulane Univ Med Fac. 1958 Aug;17(4):249-58.
8
[Prothrombin determination during the first ten days in full term newborn and in premature].[足月新生儿和早产儿出生后头十天的凝血酶原测定]
Lyon Med. 1953 Aug 2;189(31):65-72.
9
[Pseudocholinesterase and liver diseases; new method of determination].[假性胆碱酯酶与肝脏疾病；新的测定方法]
Acta Gastroenterol Belg. 1954 Feb;17(2):102-9.
10
Identification of pseudocholinesterase in the tissues of ruminants.
Nature. 1955 Oct 22;176(4486):783-4. doi: 10.1038/176783b0.
引用本文的文献
1
Butyrylcholinesterase is a potential biomarker for Sudden Infant Death Syndrome.丁酰胆碱酯酶是婴儿猝死综合征的一个潜在生物标志物。
EBioMedicine. 2022 Jun;80:104041. doi: 10.1016/j.ebiom.2022.104041. Epub 2022 May 6.
2
Incorporating children's toxicokinetics into a risk framework.将儿童毒代动力学纳入风险框架。
Environ Health Perspect. 2004 Feb;112(2):272-83. doi: 10.1289/ehp.6013.
3
Unexpected hazards associated with drugs and chemicals.与药物和化学品相关的意外危害。
Can Med Assoc J. 1962 Apr 21;86(16):721-4.
4
Congenital biliary atresia.先天性胆道闭锁
Br Med J. 1960 Oct 29;2(5208):1253-7. doi: 10.1136/bmj.2.5208.1253.
5
Apnoea following suxamethonium: the genetic study of four generations of a family.琥珀酰胆碱后的呼吸暂停：一个家族四代人的遗传学研究
J Med Genet. 1982 Feb;19(1):22-5. doi: 10.1136/jmg.19.1.22.
6
Plasma cholinesterase activity in newborns and infants.新生儿和婴儿的血浆胆碱酯酶活性
Can Anaesth Soc J. 1971 May;18(3):278-85. doi: 10.1007/BF03025463.
7
Clincial pharmacokinetics in neonates.新生儿临床药代动力学。
Clin Pharmacokinet. 1976;1(2):81-98. doi: 10.2165/00003088-197601020-00001.
本文引用的文献
1
The inhibitory action of eserine upon choline-esterase in vivo.毒扁豆碱在体内对胆碱酯酶的抑制作用。
Biochem J. 1935 Sep;29(9):2242-5. doi: 10.1042/bj0292242.
2
The cholinesterase activity of the serum on newborn animals, and of colostrum.新生动物血清及初乳中的胆碱酯酶活性。
Biochem J. 1949;45(4):493-6. doi: 10.1042/bj0450493.
3
Blood cholinesterase levels and range of personal variation in a healthy adult population.健康成年人群的血液胆碱酯酶水平及个体差异范围。
Br Med J. 1951 Oct 6;2(4735):812-6. doi: 10.1136/bmj.2.4735.812.
4
The response of the newborn infant to muscle relaxants.新生儿对肌肉松弛剂的反应。
Br J Anaesth. 1955 Mar;27(3):124-30. doi: 10.1093/bja/27.3.124.
5
Serum cholinesterase activity in the normal individual and in people with liver disease.正常个体及肝病患者的血清胆碱酯酶活性
Ann Intern Med. 1954 Sep;41(3):533-45. doi: 10.7326/0003-4819-41-3-533.
Zotero 插件